ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $70,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 1,652,190 | $3,817,000 | 2.58% |
| LINCOLN CAPITAL CORP | 62,000 | $143,000 | 0.13% |
| Laurion Capital Management LP | 1,944,727 | $4,492,000 | 0.08% |
| Cedar Wealth Management, LLC | 46,395 | $107,000 | 0.08% |
| Fosun International Ltd | 301,708 | $709,000 | 0.04% |
| BCWM, LLC | 35,100 | $811,000 | 0.04% |
| Engineers Gate Manager LP | 170,800 | $395,000 | 0.03% |
| Alpine Global Management, LLC | 45,211 | $104,000 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $578,000 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 73,778 | $170,000 | 0.02% |